As of 3:59pm ET
| +0.0033 / +1.83%|
iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals. The company was founded on April 15, 1993 and is headquartered in New York, NY.
|Robert B. Kay||Executive Chairman & Chief Executive Officer|
|Robert L. Erwin||President|
|James P. Mullaney||Chief Financial Officer|
|Terence E. Ryan||Chief Scientific Officer|
|Douglas C. Hicks||Senior VP-Business Development & Strategy|